Eli Lilly & Co. vs Medpace Holdings, Inc.
LLY vs MEDP — side-by-side comparison from reported financials. LLY leads 7, MEDP leads 2 of 9 comparable metrics.
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
Medpace Holdings, Inc.
MEDP · Healthcare
$612.05+1.55%Strained
| Metric | LLY | MEDP |
|---|---|---|
| Price | $1 177.20 | $612.05 |
| Market cap | $1.05T | $17.1B |
| Revenue (TTM) | $79.7B | $2.78B |
| Revenue growth | +31.7% | +20.1% |
| Net margin | 33.5% | 17.7% |
| Free cash flow | $18.2B | $707M |
| Net cash (debt) | ($35.2B) | — |
| 1-year price return | +37.6% | +18.0% |
| P/E | 41.6 | 34.8 |
| P/E vs own history (cheap-side %) | 88% | 30% |
| Dividend yield | 0.52% | — |
| Return on equity | 93% | 110% |
| Altman Z-score | 7.10 | — |
| CV checks passed | 11 of 11 | 8 of 11 |
| Employees | 50,000 | 6,500 |
Full résumé-style profiles: LLY CV · MEDP CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.